Tissue Therapies
HOME TECHNOLOGY INVESTORS ALLIANCES COMPANY
CONTACT




HOME COMPANY THE BOARD GREG BAYNTON   
GREG BAYNTON :: DIRECTOR
MBA, M.Econ St., PG Dip. App. Finance & Investment, B.Bus. (Accountancy)

Greg Baynton is Managing Director of Orbit Capital, a private investment bank and holder of an Australian Financial Services Licence. He comes from a background in merchant banking and Queensland Treasury. He is founder of a junior ASX-listed oil and gas exploration company, a Director of, and corporate advisor to a junior ASX-listed gold explorer. He serves on the boards of three emerging Australian biotechnology companies. He has been directly involved in structuring, establishing, raising capital and managing new ventures in a diverse group of industries in recent years from pre-seed opportunities to Initial Public Offerings.

Greg holds a Masters of Economic Studies (UofQ), an MBA in New Venture Management (QUT), a Graduate Diploma in Applied Finance and Investment (SIA), and a Bachelor of Business (Accountancy). He is also a Fellow of the Australian Institute of Company Directors and an Associate of the Securities Institute of Australia.


© 2007 TISSUE THERAPIES LTD